RA Capital Healthcare Fund disposes of 213 Vor Biopharma shares worth $4,206.75
VOR•RA Capital filing details
RA Capital Management, a 10% owner of Vor Biopharma, reported acquiring 2.1 million common shares on July 16, 2026 at $0.002 each.
The filing also showed a disposition of 213 common shares at $19.75.
Reported holdings after the transactions
RA Capital reported 4,501,882 common shares beneficially owned following the transactions.
It also reported 7,900,000 pre-funded warrants outstanding, exercisable at $0.002, priced at $5.
